Title : New strategies in metastatic prostate cancer: targeting the androgen receptor signaling pathway.

Pub. Date : 2011 Apr 1

PMID : 21372223






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Recent data report that abiraterone acetate, a specific inhibitor of CYP17 that is key to androgen and estrogen synthesis, improves survival in metastatic castration-resistant prostate cancer (CRPC), confirming the continued dependency of CRPC on the androgen receptor (AR) signaling pathway. Abiraterone Acetate androgen receptor Homo sapiens
2 Recent data report that abiraterone acetate, a specific inhibitor of CYP17 that is key to androgen and estrogen synthesis, improves survival in metastatic castration-resistant prostate cancer (CRPC), confirming the continued dependency of CRPC on the androgen receptor (AR) signaling pathway. Abiraterone Acetate androgen receptor Homo sapiens